AXIN1 in Plasma or Serum Is a Potential New Biomarker for Endometriosis
This study found that plasma and serum levels of AXIN1 were significantly elevated in women with endometriosis compared to control groups, suggesting it is a potential new diagnostic biomarker.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- Are digestive symptoms in women presenting with pelvic endometriosis specific to lesion localizations? A preliminary prospective study via openalex
- Biomarkers in endometriosis: challenges and opportunities via openalex
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Can chemokines be used as biomarkers for endometriosis? A systematic review via openalex
- Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive via openalex
- Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case–control study—Part 2 via openalex
- Endometriosis-associated changes in serum levels of interferons and chemokines via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Targeting the Wnt/β-catenin pathway in endometriosis: a potentially effective approach for treatment and prevention via openalex
- The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases via openalex
- The plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 are elevated in patients with endometriosis via openalex
- The role of the peritoneum in the pathogenesis of endometriosis via openalex
- Update on Biomarkers for the Detection of Endometriosis via openalex
- Visceral hypersensitivity in endometriosis: a new target for treatment? via openalex
- W2072061825 via openalex
- W2094067819 via openalex
- W2152081967 via openalex
- W2302794943 via openalex
- W2592430395 via openalex
- W2604780989 via openalex
- W2883981220 via openalex
- W2923349683 via openalex
- W3009538581 via openalex
- W4206485580 via openalex
- W4211081176 via openalex
- W6628680024 via openalex
- W6637338146 via openalex
- W1683418430 via openalex
- W1971055570 via openalex
- W1971797728 via openalex
- W1972614730 via openalex
- W1982516973 via openalex
- W1990953301 via openalex
- W1999816675 via openalex
- W2010084870 via openalex
- W2011192433 via openalex
- W2037607955 via openalex
- W2046208657 via openalex
- W2056539843 via openalex
- W2061538346 via openalex
- W2068900428 via openalex
- W2069083706 via openalex
- W2069300364 via openalex
- W2070687006 via openalex
Cited by (17)
- Deciphering the potential of proteomic-based biomarkers in women’s reproductive diseases: empowering precision medicine in gynecology 2024
- Endometrioid ovarian cysts: risk factors for recurrence 2024
- Endometriosis-Associated Infertility: The Role of Biomarkers of Apoptosis and Proliferation in Early Noninvasive Diagnosis 2024
- Proteomics in the study of female fertility: an update 2023
- Additional file 2 of Applicability of polygenic risk scores in endometriosis clinical presentation 2022
- Endometriosis Research: From Bench to Bedside 2022
- TSH receptor antibodies (TRAb) – A potential new biomarker for endometriosis 2022
- Additional file 1 of Applicability of polygenic risk scores in endometriosis clinical presentation 2022
- Additional file 3 of Applicability of polygenic risk scores in endometriosis clinical presentation 2022
- Applicability of polygenic risk scores in endometriosis clinical presentation 2022
- Associations Between Endometriosis and Gut Microbiota 2021
- Endometriosis and adverse pregnancy outcome 2021
- Bioinspired Long-Wavelength Excitable Near-Infrared AIEdots for Endometriosis Targeting and Image-Guided Surgery 2021
- Bioinspired Long-Wavelength Excitable Near-Infrared AIEdots for Endometriosis Targeting and Image-Guided Surgery 2021
- Inflammatory Mediators and Pain in Endometriosis: A Systematic Review 2021
- Plasma AXIN1 expression exhibit negative correlations with inflammatory biomarkers and is associated with gastrointestinal symptoms in endometriosis 2020
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:23:01.605684+00:00